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The Tac4 gene-derived hemokinin-1 (HK-1) is present in pain-related regions and activates the tachykinin NK1 receptor, but with binding site and signaling pathways different from Substance P (SP). NK1 receptor is involved in nociception, but our earlier data showed that it has no role in chronic neuropathic hyperalgesia, similarly to SP. Furthermore, NK1 antagonists failed in clinical trials as analgesics due to still unknown reasons. Therefore, we investigated the role of HK-1 in pain conditions of distinct mechanisms using genetically modified mice.
Chronic neuropathic mechanical and cold hyperalgesia after sciatic nerve ligation were determined by dynamic plantar aesthesiometry and withdrawal latency from icy water, motor coordination on the accelerating Rotarod. Peripheral nerve growth factor (NGF) production was measured by ELISA, neuronal and glia cell activation by immunohistochemistry in pain-related regions. Acute somatic and visceral chemonocifensive behaviors were assessed after intraplantar formalin or intraperitoneal acetic-acid injection, respectively. Resiniferatoxininduced inflammatory mechanical and thermal hyperalgesia by aesthesiometry and increasing temperature hot plate.
Chronic neuropathic mechanical and cold hypersensitivity were significantly decreased in HK-1 deficient mice. NGF level in the paw homogenates of intact mice were significantly lower in case of HK-1 deletion. However, it significantly increased under neuropathic condition in contrast to wildtype mice, where the higher basal concentration did not show any alterations.
Microglia, but not astrocyte activation was observed 14 days after PSL in the ipsilateral spinal dorsal horn of WT, but not HK-1-deficient mice. However, under neuropathic conditions, the number of GFAP-positive astrocytes was significantly smaller in case of HK-1 deletion. Acute visceral, but not somatic nocifensive behavior, as well as neurogenic inflammatory mechanical and thermal hypersensitivity were significantly reduced by HK-1 deficiency similarly to NK1, but not to SP deletion. 
INTRODUCTION
Pain is one of the most common medical and socio-economical problems world-wide. It can originate from several sources e.g. trauma, inflammation, cancer, metabolic diseases. The most debilitating and therapeutically challenging form is neuropathic pain, which is a very typical symptom of diabetes, genetic diseases and nerve injury (Dineen and Freeman, 2015) . In many cases the presently available pharmacotherapy is not satisfactory, there are several therapy-A C C E P T E D M A N U S C R I P T resistant patients and the adjuvant analgesics currently in use (tricyclic antidepressants, antiepileptics) have common and severe side effects (Watson and Dyck, 2015) . Therefore, neuropathic pain is still an unmet medical need; understanding the underlying mechanisms and finding new key molecules is essential in determining new therapeutic targets.
Tachykinins are one of the oldest and most investigated group of neuropeptides. There are several data available about their location and broad range of functions, the drug developmental potential of Substance P (SP) and its tachykinin NK1 receptor have been studied for decades.
The discovery of the newest member of the tachykinin family, hemokinin-1 (HK-1) changed our knowledge about these neuropeptides (Zhang et al., 2000) . There is no doubt that tachykinins and their receptors are present and play a pivotal regulatory role in many functions of the airways, GI and urinary tracts, as well as central and peripheral nervous systems (CNS, PNS; Steinhoff et al., 2014) . Furthermore, not only the neurons, but also glia cells express the NK1 receptor with discrepancies between spinal cord and brain, as well as between rodents and humans (Marriott, 2004) . Clinical data also suggest the importance of SP and NK1 in pain states: elevated SP level was measured in patients with trigeminal neuralgia (Qin et al., 2016) or fibromyalgia (Tsilioni et al., 2016) . Although agents that block the effect of SP on the NK1 receptor were very promising analgesic drug candidates based on animal models, they failed in clinical trials (Hill, 2000) . There are several theories about their ineffectiveness including species-specific NK1 pharmacology, problems with the clinical trials, broad spectrum of transmitters involved in pain (Herbert and Holzer, 2002) , but the answer still remains unclear.
Another explanation might be the presence and modulatory function of HK-1 that can bind to different regions of the NK1 receptor, induce different signaling pathways as compared to SP, and can also act at other targets. Comparison of SP and HK-1 to reevaluate the previous results is particularly important to provide a better overview about the function of the tachykinin family.
The Tac4 gene-derived HK-1 is different from the other members of the tachykinin family, its predominant expression on the periphery, and lower but characteristic distribution in the brain (Duffy et al., 2003) have proposed a unique function for this peptide. Besides the immune system, its role in the nociceptive pathway and pain states is the most intensively investigated issue. However, based on present knowledge it is not clear whether HK-1 is pro-or antinociceptive , and whether it acts via its preferred NK1 receptor.
Therefore, we aimed to investigate the role of HK-1 in the pathophysiology of neuropathic and inflammatory pain to unravel its function and mechanisms.
MATERIALS AND METHODS

Animals
Experiments were carried out on Tac1 (Tac1 -/-), Tac4 (Tac4 original breeding pairs of the Tac1 -/-and Tacr1 -/-mice were obtained from the University of Liverpool, UK (Zimmer et al., 1998; De Felipe et al., 1998) , while those of the Tac4 -/-mice were donated by Berger et al. (2010) . Transgenic mice with deletion of Tac1, Tac4 or Tacr1 were generated on a C57Bl/6 background and backcrossed to homozygosity for > 5 generations prior to using C57Bl/6 mice as controls, purchased from Charles-River Ltd. (Hungary).
Germline transmission of the mutated allele and excision of the selection cassette were verified by PCR analysis. Animals were bred and kept in conventional animal house of the Department of Pharmacology and Pharmacotherapy, University of Pécs at 24-25°C, 12 hours light/dark cycles. Animals were provided standard diet and water ad libitum. Mice were housed in groups of 5-10 in polycarbonate cages (330 cm 2 floor space, 12 cm height) on wood shaving bedding.
Behavioral tests and perfusion were carried out in the laboratory of the Department in the
The animals had a 60-min period prior each experiment for acclimatization. The investigator was always blinded to the treatments and the genotypes of the mice.
Ethics
All experiments were carried out according to the 
Investigation of neuropathic pain (partial sciatic nerve ligation, PSL)
Traumatic mononeuropathy was induced by the 1/3-1/2 ligation of the right sciatic nerve, or partial sciatic nerve ligation (Seltzer et al, 1990.) under ketamine (100 mg/kg, i.p) and xylazine (10 mg/kg, i.m.)-induced anesthesia. In sham-operated group sciatic nerve was located, but not ligated. Mechanonociceptive threshold was characterized by the force exerted by a straight metal filament -when the animal removed its hindpaw, and it was assessed with a dynamic plantar aesthesiometer (Ugo Basile 37000, Comerio, Italy). Measurements were performed 3, 5, 7, 10, 14, 19 days after operation, and mechanical hyperalgesia was expressed as percentage change of mechanonociceptive threshold in comparison to the initial, control value (Helyes et al, 2004) . Cold tolerance was examined with the latency of paw-withdrawal from 0 o C water, and the change was compared to the pre-operative control measurements of each mice (Tékus et al., 2014) . Motor coordination was examined with the accelerating Rota Rod 7, 10 and 19 days after operation (Ugo Basile, Comerio, Italy; Botz et al., 2013) .
Measurement of nerve growth factor (NGF) concentration in the paw
Nerve growth factor (NGF) is a member of a family of growth and survival factors known as neurotrophins. Enzyme-linked immunosorbent assay (ELISA) was applied in order to determine NGF expression at the level of protein using ChemiKine Nerve Growth Factor Sandwich ELISA Kit (Chemicon International, catalog nr: CYT304). Measurement was performed according to the manufacturer's instructions. Shortly, sheep polyclonal antibodies generated against mouse NGF were coated on a 96-well plate. Samples and standards were incubated overnight on the plate to let any NGF present in the sample bound to the immobilized antibodies. After removal of unbound biological components by washing, indirect labelling was performed using mouse anti-mouse NGF monoclonal primary antibody and peroxidase conjugated donkey anti-mouse IgG polyclonal antibodies. The formed immunocomplex was incubated with TMB/E Substrate. Enzyme reaction was stopped with HCl solution and color intensity was detected immediately using Labsystem Multiscan RC plate reader. Results were calculated after plotting of a standard curve and are given in pg/g tissue homogenate.
Examination of glial and neuronal activation with immunohistochemistry
The mice had their last pain threshold measurement on the 7 th postoperative day, and returned to the animal house for 7 days of rest to allow the increase in FosB protein caused by handling to subside. On the 14 th day after operation, the mice were perfused with 4% paraformaldehyde, and their spinal cord and brain were removed. Immunohistochemistry of the brains of C57Bl/6
and Tac4 -/-animals was performed as it was previously described in detail (Gaszner et al., 2012) . In brief, sections were cut for free-floating diaminobenzidine (Sigma-Aldrich Ltd, Missouri, USA) immunohistochemistry after marking the operated (right) side of the tissues with alcian blue stain (Merck, Darmstadt, Germany). Polyclonal rabbit antiserum against Iba1
(Wako Biochemicals, Osaka, Japan) and FosB (Santa Cruz Biotechnology Inc., Dallas, USA), monoclonal mouse antibody against GFAP protein (Leica Biosystems, Wetzlar, Germany). 
Examination of formalin-induced acute somatic nocifensive behavior
Acute somatic chemonociception was elicited by formalin (Formaldehydum solutum 37%;
Ph.Hg. VII.; 50 μl, 2.5%) injected subcutaneously (s.c.) into the plantar surface of the right hindpaw. Nocifensive behavior -including the lifting, licking and shaking movement of the treated hindpaw -developed in two phases. The evolvement of the first phase (0-5 min, early phase) is thought to occur due to a direct activation of sensory nerve terminals, while the second one (20-45 min, late phase) develops mainly as a result of the release of acute inflammatory mediators (Tjolsen et al., 1992) . Quantitative evaluation of the nocifensive reaction was performed in both examination periods: the duration of paw liftings and lickings was determined (Bölcskei et al., 2005; Sándor et al., 2010) .
Investigation of acetic acid-evoked acute visceral nocifensive reaction (writhing test)
In order to investigate acute visceral chemonociception, intraperitoneal (i.p.) administration of acetic acid (0.2 ml per mouse, 0.6%) was carried out. As a result of chemical irritation of the peritoneum, abdominal contractions (writhing movements) occurred, regarded as typical sign of visceral nocifensive behavior. For quantitative assessment of this reaction, animals were
placed in a transparent plastic box immediately after the injection and the amount of writhing movements was counted during the 0-5, 5-20 and 20-30 min time intervals (Sándor et al., 2007) .
Investigation of resiniferatoxin (RTX)-induced acute thermal allodynia and mechanical hyperalgesia
Acute neurogenic inflammation of the right hindpaw was evoked by intraplantar injection of the ultrapotent Transient Receptor Potential Vanilloid 1 (TRPV1) receptor agonist resiniferatoxin (RTX; 20 µl, 0.03 µg/ml i.pl.). RTX evokes an acute neurogenic inflammatory reaction including the evolvement of a rapid thermal allodynia, and a subsequent mechanical hyperalgesia (Meyer and Campbell, 1981) . Thermal allodynia was expressed as the drop of noxious heat threshold compared to the pre-injection control value. Noxious heat threshold was defined as the temperature where the animal first showed nocifensive behavior (lifting, licking or shaking of the hindpaw), and it was determined with an increasing temperature hot plate (IITC Life Science, Woodland Hills, CA, USA) prior to RTX-injection and 5, 10, 15 and 20 min following the treatment. Mechanical hyperalgesia was assessed by dynamic plantar aesthesiometry as described for the neuropathy model (see above) before the induction of inflammation and 2, 4, 6 and 24 h afterwards (Sándor et al., 2010) .
Statistical analysis
Results are expressed as mean±SEM of n=4-16 mice per group in case of in vivo functional tests. Data obtained in these experiments were analysed with repeated measures two-way ANOVA followed by Bonferroni's posttest with GraphPad Prism 5 software (La Jolla, USA).
The data of the immunohistological staining, due to the larger number of groups, was analysed
with factorial ANOVA and Tukey's posttest with Statistica software (TIBCO Inc., Palo Alto, USA). In all cases p<0.05 was accepted as statistically significant.
RESULTS
Decreased neuropathic hyperalgesia and worse motor performance in HK-1 deficient mice
Compared to the pre-operation control values (9.29±0.07g in the WT and 9.10±0.09g in the gene-deleted group), significant mechanical hyperalgesia developed by day 5 after the sciatic nerve ligation in the WT group, reaching its maximum of -48.46±4.01% on day 10, which was maintained until the end of the study. In the Tac4 -/-group neuropathic mechanical hyperalgesia was significantly smaller throughout the whole experiment with the maximum of -29.03±2.30%
on day 10 ( Fig. 2A) .
The basal withdrawal latency from 0 o C water was 158.60±4.09 and 147.41±3.49 sec in the WT and Tac4 gene-deleted groups, respectively. Withdrawal latency decreased earlier than the mechanonociceptive threshold, cold hyperalgesia developed on the 3 rd postoperative day in the WT group, which was significantly smaller in the HK-1 deficient one until day 7, when the difference was not statistically significant any more (Fig. 2B) .
The basal motor performance on the accelerating RotaRod was 56.64±5.28 sec in the WT and 38.13±8.38 sec in the HK-1-deficient group. This statistically not significant basal difference was also observed later, when repeating this measurement, and reached statistical significance on day 10. Despite the sensory changes, nerve ligation did not significantly alter the motor performance (Fig. 2C) .
Lower peripheral NGF concentration in HK-1-deficient mice increases after nerve injury
The NGF concentration of the paw homogenates was significantly lower in intact Tac4 -/-mice compared to WTs. Under neuropathic condition, 7 days after PSL -when the postoperative pain component is not relevant anymore, and both mechanical and cold hyperalgesia are stabile -NGF level was not altered in the WT group, but showed an almost 2-fold elevation in the HK-1-deficient one (Fig. 2D) .
HK-1 mediates microglia activation in the spinal dorsal horn after PSL-induced neuropathy
In the spinal dorsal horn, the number of Iba1-immunopositive microglia did not differ under The number of GFAP-positive astrocytes were very similar in the spinal dorsal horn of both WT and HK-1-deficient mice under intact conditions. Despite the PSL-induced microgliosis described above, astrocyte numbers did not increase significantly in the WT group either ipsior contralaterally but interestingly even decreased in the Tac4 -/-one on both sides (Figs. 4C, D) .
The chronic neuronal activation marker FosB-immunopositivity did not show any alterations in relation to genotype, PSL or side (Figs. 4E, F) .
In pain-related brain regions, such as the PAG, amygdala and somatosensory cortex the number of Iba1-positive microglia was very similar in both groups, both under intact and neuropathic conditions. The GFAP-positive astrocyte counts were very low (below 4-5 cells/mm 2 ) in these regions, and therefore statistically significant alterations were not detectable except for the lateral PAG, where significantly lower GFAP-immunopositivity was measured in intact HK-1- In sham-operated mice significant changes of microglia, astrocyte or activated neuron counts were not observed compared to intact mice in any regions.
HK-1 mediates acute visceral nociception, inflammatory thermal allodynia and mechanical hyperalgesia
In WT mice, the total duration of formalin-induced paw lickings, liftings and shakings was 128.54±16.80 sec in the early phase referring to acute somatic chemonociception and 440.69±35.74 sec in the late phase evoked by neurogenic inflammatory mechanisms. There was no significant difference between Tac4 gene-deleted mice and WT mice in either phase ( of an early thermal allodynia, which was maintained at a stable level throughout the 20-min investigation period. In contrast, in Tac4 -/-mice this thermal allodynia was significantly attenuated compared to the WTs (Fig. 5C ).
The basal mechanonociceptive thresholds of WT and Tac4 -/-mice were 7.26±0.16g and 8.13±0.17g, respectively. There was a 34.05±2.47% drop of the mechanonociceptive threshold (mechanical hyperalgesia) in WT mice 2 h after RTX injection that decreased to -20.67±2.97%
by the 24 h time point. However, in Tac4 -/-mice this later developing mechanical hyperalgesia was also significantly reduced in comparison to the WTs during the whole investigation period (Fig. 5D ).
In order to investigate whether the effects of HK-1 are similar to SP and mediated by NK1 receptors, we also included Tac1 -/-and Tacr1 -/-mice in our studies. Formalin-induced somatic nocifensive behavior was significantly reduced in the late phase in Tac1 -/-mice, but not in Tacr1 -/-ones (Fig. 6A) . Acetic acid-evoked writhing movements were significantly decreased both in the Tac1 -/-and Tacr1 -/-mice in the second and third phases (Fig. 6B) . RTX-induced thermal hyperalgesia was abolished in the Tac1 -/-mice but in the Tacr1 -/-group significant decrease was only detected at the last, 20-min timepoint (Fig. 6C) . However, mechanical hyperalgesia in this model was significantly attenuated in the Tacr1 -/-mice, but not in the Tac1 -/-group (Fig. 6D ).
Discussion
With the help of gene-deleted mice we provided clear evidence that the Tac4 gene-encoded HK-1 is an important mediator of chronic neuropathic mechanical and cold hyperalgesia, microglia-and astrocyte activation in the spinal dorsal horn, and peripheral NGF-production.
Furthermore, HK-1 is also involved in acute inflammatory thermal allodynia involving mainly peripheral mechanisms, as well as mechanical hyperalgesia including both central and peripheral sensitization. HK-1 participates in acute visceral chemonociception as well. We provided the first functional data for a role of HK-1 in motor coordination, which is supported by very high Tac4 mRNA expression in the cerebellum (Duffy et al., 2003) .
Data about the role of HK-1 and related peptides in humans such as hHK-1, hHK-1(4-11) and endokinins in pain after their central administration are controversial. Intracerebroventricular injection of HK-1 induced pain responses like foot-tapping in gerbils and scratching in mice Duffy et al., 2003) , intrathecal administration caused scratching in rats (Endo et al., 2006) .
HK-1-induced pain reactions were suggested to be mediated by the interaction with the glutamate system in the spinal cord (Watanabe et al., 2016) . Intrathecally administered endokinin A/B (EKA/B)-evoked scratching behavior and thermal hyperalgesia, while EKC/D did not . In contrast, several data reported analgesic effects of HK-1, and suggested potential interactions with the opioid system (Fu et al., 2005; Fu et al., 2008, Yang and Dong, 2010) . The virtually contradictory actions of hemokinins and endokinins in pain might be explained by its divergent actions in the CNS and in the periphery, as well as by the different doses applied. It was established to contribute to immune activation (NaonoNakayama et al., 2010a; Sumpter et al., 2015, for review see , which can be a factor in inflammatory pain. Microglia -the resident macrophages of the central nervous system -are known to increase HK-1 production when activated (Sakai et al, 2012) , and HK-1-production could be decreased by blocking glia activation in neuropathic rats, as well as their pain-related behaviour (Matsumura, 2008) . There is no information regarding direct interactions of NGF and HK-1 in inflammation and pain, but it is known that NGF is an important factor of nociceptor development and the activation of peptidergic C-fibers releasing proinflammatory neuropeptides, including SP via its tyrosin kinase-linked receptors (Woolf et al, 2007) . We describe the first results, that in the absence of HK-1, peripheral NGF level increases during neuropathic conditions, which might contribute to the heeling of the damaged peripheral nerve fibres resulting in decreased hyperalgesia (Siniscalco et al, 2011) .
Concerning the target and mechanism of action, our present data in comparison with previously published results clearly demonstrates that in chronic neuropathic hyperalgesia HK-1 does not mediate its pronociceptive effect via the NK1 receptor (Botz et al., 2013) despite inflammatory hyperalgesia in the adjuvant-induced chronic arthritis model (Borbély et al., 2013) . Several data suggests that some of the HK-1 effects are mediated by other targets, presumably its own
receptor and/or through an NK1 receptor binding pocket different from SP (Endo et al., 2006; Watanabe et al., 2010; Borbély et al., 2013; Hajna et al., 2015; . The complexity of HK action is also illustrated by the analgesic effects of hHK-1, but not its shorter fragment hHK-1(4-11) through NK1 receptor (Fu et al., 2008 ).
While we again showed that SNL does not cause impairment in the RotaRod test (Botz et al., 2013) , we demonstrated that HK-1 deficient mice have worse motor performance. This can be explained by particularly high expression of Tac4 mRNA in the cerebellum (Duffy et al., 2003) .
This function is likely not mediated via the NK1 receptor, as similar results were found in mice lacking SP, but not NK1 receptor (Botz et al, 2013.) .
The present results revealed that in contrast to chronic neuropathy SP and NKA, but not HK-1 and NK1 receptor mediate acute somatic nocifensive behaviors. SP/NKA might exert these actions by the NK2 receptor in this process. However, HK-1 is involved in the development of acute visceral chemonociception and inflammatory thermal hyperalgesia due to peripheral sensitization of the nociceptors similarly to SP/NKA, mainly via NK1 receptor activation.
However, under inflammatory conditions, where central sensitization in the spinal dorsal horn plays an important role besides peripheral mechanisms at the nerve terminals, NK1 receptor seems to be activated primarily by HK-1 and not by SP/NKA.
Interestingly, our investigations also revealed that in SP-deficient mice the acetic-acid-evoked nocifensive behavior was significantly less intensive, although previous reports only described a tendentious difference (Zimmer et al., 1998) . The fact that we performed a longer and more detailed set of analysis is likely to explain these findings.
Our conclusion that HK-1 is differently involved in pain processing compared to SP/NKA is strongly supported by the literature. Although centrally administered HK-1 induced scratching response similarly to SP (Duffy et al., 2003; Endo et al., 2006) , it did not influence the
withdrawal latency to noxious thermal stimulation unlike SP (Endo et al., 2006) . Moreover, HK-1 and SP differently modulated the nocifensive behavior in response to activation of several TRP channels (Naono-Nakayama et al., 2010b) . The expression pattern of HK-1 differs from that of SP: HK-1 is present in a much broader range of peripheral tissues, but at a lower level in the CNS compared to SP (Duffy et al., 2003) . Furthermore, baseline Tac1 mRNA expression was higher than Tac4 in the dorsal spinal cord, but under neuropathic conditions only Tac4 expression increased significantly in rats (Matsumura et al., 2008) . These can also provide an explanation for our findings that HK-1 differently contributes to neuropathic and inflammatory pain as compared to SP.
Our present study also revealed that HK-1 plays a predominant role in mechanical hyperalgesia not only under chronic traumatic neuropathic, but also under acute inflammatory conditions.
These results are in accordance with our previous data in the adjuvant-induced arthritis model, where HK-1 was shown to mediate chronic inflammatory mechanical hyperalgesia (Borbély et al., 2013) . Despite its considerably lower expression in the CNS compared to SP, HK-1 does contribute to the development of mechanical hyperalgesia involving both peripheral and central sensitization, while these tachykinins do not play a role in thermal hyperalgesia mediated by peripheral sensitization (Meyer et al., 2006) . This is a very important result in the characterization of the neurobiology of HK-1.
Conclusion
HK-1 is an important mediator of chronic neuropathic pain via a non-NK1 receptor-mediated pathway. It activates microglia in the spinal dorsal horn and suppresses nerve damage-induced peripheral NGF production. Moreover, it also participates in acute inflammatory thermal allodynia and mechanical hyperalgesia, as well as acute visceral chemonociception, presumably through NK1 receptor activation. These findings help to better understand the pathophysiology of pain and might contribute to the development of novel analgesics. 
